The benefit of dupilumab as a postoperative short‐term adjuvant therapy for chronic rhinosinusitis with nasal polyps: A preliminary study

Abstract Introduction Recent evidence recommends the use of biologics in patients with severe uncontrolled type 2 chronic rhinosinusitis with nasal polyp (CRSwNP) owing to its propensity for recurrence after functional endoscopic sinus surgery (FESS). Among the type 2 biologics used for the treatmen...

Full description

Bibliographic Details

Published in:	Laryngoscope Investigative Otolaryngology
Main Authors:	Pei‐Wen Wu, Chi‐Che Huang, Po‐Hung Chang, Ta‐Jen Lee, Chien‐Chia Huang
Format:	Article
Language:	English
Published:	Wiley 2024-08-01
Subjects:	adjuvant therapy biologic chronic rhinosinusitis with nasal polyp dupilumab functional endoscopic sinus surgery
Online Access:	https://doi.org/10.1002/lio2.1296